Niddk: supply: CFX opus 384 real-time PCR system and chemidoc go imaging system

Ended Purchase Order Awarded Last action

Contract number
75N94025P00650
Awardee
Awarding agency
Obligated
$59,998

Award facts

Opportunity
Contract value 100% obligated
$59,998.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health, Department of Health and Human Services
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 5 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Rodeo, CA 94547, USA

Award details come from SAM.gov/FPDS.

About this award

Bio-Rad Laboratories, Inc. (Life Science Group Division) was awarded a $59,998 firm fixed-price purchase order by the National Institute of Diabetes and Digestive and Kidney Diseases on September 25, 2025, with a completion date of November 24, 2025. The contract covers the supply of a CFX Opus 384 Real-Time PCR System and a ChemiDoc GO Imaging System, which will be delivered to the performance location in Hercules, California. This acquisition was not designated as a small business set-aside and was conducted through Simplified Acquisition Procedures based on solicitation number 75N94025Q00236, which was posted on September 8, 2025, with responses due by September 15, 2025.

Bio-Rad Laboratories is a well-established federal contractor and global leader in life science research instrumentation, headquartered in Hercules, California. The company maintains a significant presence across federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Department of Veterans Affairs, with a substantial $10 million Blanket Purchase Agreement active through December 31, 2025. The CFX Opus 384 Real-Time PCR System and ChemiDoc imaging equipment support advanced molecular biology research capabilities essential to NIDDK's mission in diabetes, digestive, and kidney disease research, representing specialized laboratory instrumentation that aligns with Bio-Rad's core portfolio of PCR systems, thermal cyclers, and gel imaging systems.

Quick answers

Who was awarded contract 75N94025P00650?

75N94025P00650 was awarded to Bio-Rad Laboratories, Inc. by National Institute of Child Health and Human Development (National Institutes of Health) on September 25, 2025.

How much is contract 75N94025P00650 worth?

The government has obligated $59,998 on 75N94025P00650.

Which agency awarded contract 75N94025P00650?

National Institute of Child Health and Human Development (National Institutes of Health) awarded 75N94025P00650, with funding from National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health).

Was contract 75N94025P00650 competed?

The extent of competition for 75N94025P00650 was competed under sap. The government received 5 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award